EGFR and lung adenocarcinoma: The epidermal growth factor receptor (EGFR) gene has been found mutated in about 15% of Caucasian patients, and up to 50% or more in Asian patients with lung adenocarcinomas [4], and its driver mutations were the first ones to be targeted in lung cancer.